跳至主要内容
临床试验/JPRN-UMIN000004947
JPRN-UMIN000004947招募中未知

An open-label randomized controlled study on the efficacy and safety of vitamin D plus peginterferon alpha 2a/ribavirin in elder women with chronic hepatitis C - Effects of vitamin D plus peginterferon alpha 2a/ribavirin in elder women with chronic hepatitis C

Gifu University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2011年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • Patients are excluded if they have decompensated liver diseases, other causes of liver diseases, hepatitis B infection, hemoglobin values <12 g/dl, white blood cell count <3000/ul, thrombocytopenia <90,000/ul, neoplastic, severe cardiac, neurological, autoimmune or thyroid diseases. Also excluded were patients with alcohol or drug abuse, women who were pregnant or considering pregnancy in the next 18 months, or men whose partners were considering pregnancy in the next 18 months.

研究者

发起方
Gifu University Graduate School of Medicine

相似试验